J Alzheimers Dis 61:545552 Cao Y, Holscher C, Hu MM, Wang T, Zhao F, Bai Y, Zhang J, Wu MN, Qi JS (2018b) DA5-CH, a novel GLP-1/GIP dual agonist, effectively ameliorates the cognitive impairments and pathology in the APP/PS1 mouse model of Alzheimers disease
Insoluble fibre does not dissolve in water and adds bulk to stool, promoting regular bowel movementsa critical function given the constipation risk associated with GLP-1 therapy
Prvention des maladies neurodgnratives Des tudes menes en laboratoire sur des modles cellulaires ou des rongeurs suggrent que la carnitine a des effets neuro-protecteurs
Besides, ISL treatment not only effectively reduced TNF- and IL-6 gene expression in LPS-induced mouse primary peritoneal macrophages but also attenuated lung and liver injuries induced by LPS, accompanied by decreased inflammatory responses, which may be strongly related to NF-B inhibition (Chen et al., 2018)
Research on postmenopausal women with overweight/obesity have indicated that those who used GLP-1 RAs combined with HRT experienced greater total body weight loss compared to those using GLP-1 RAs alone, suggesting that restored estrogen levels may enhance the metabolic efficacy of the GLP-1 medications
Research indicates that GPER expression is closely related to androgen levels, and patients with PCOS often present elevated androgen levels [157], which may lead to abnormal GPER function, thus affecting ovarian physiological functions and metabolic status [157]
